Bundibugyo Ebola trials - Health Xplore

Response Research to Emerging Infectious Diseases Inform

March 26, 2024

Skin Type Before Choosing Skin Care Products

March 26, 2024

Using Lemon on Your Face & Ways to

March 26, 2024

Most Common Exercise Machines at the Gym

March 26, 2024

Contact Info

ADDRESS: Street, City, Country
PHONE: +(123) 456 789
E-MAIL: your-email@mail.com

Tag: Bundibugyo Ebola trials

News

Bundibugyo Ebola Outbreak: WHO Identifies Vaccines and Therapeutics for Trials

WHO advisory groups recommend prioritizing three candidate therapeutics for Bundibugyo Ebola trials: Mapp Biopharmaceutical’s MBP134, Regeneron’s Maftivimab, and Gilead Sciences’ antiviral remdesivir.

imphoenix82
May 29, 2026
0 Comments
7 Views

About Us

HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.

Email Us: support@healthxploreindia.com

Contact: +91 8447496924

Response Research to Emerging Infectious Diseases Inform

Skin Type Before Choosing Skin Care Products

Using Lemon on Your Face & Ways to

Most Common Exercise Machines at the Gym

Contact Info

Tag: Bundibugyo Ebola trials

Bundibugyo Ebola Outbreak: WHO Identifies Vaccines and Therapeutics for Trials

Indian Surgeon Performs Robotic Urology Telesurgery from Wuhan.

BPL Medical Unveils New ICU Ventilator to Support.

Reach Surgical’s Ultrasonic Shears Device Approved for European.

Breast Cancer: Lupin, Natco Receive US FDA Approval.

About Us

Quick Link

Top Categories

Top Posts

Response Research to Emerging Infectious Diseases

Skin Type Before Choosing Skin Care

Using Lemon on Your Face &